Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
HMGN2	3151	broad.mit.edu	37	1	26801731	26801731	+	3'UTR	SNP	G	G	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr1:26801731G>T	ENST00000361427.5	+	0	459				HMGN2_ENST00000493418.1_3'UTR	NM_005517.3	NP_005508.1	P05204	HMGN2_HUMAN	high mobility group nucleosomal binding domain 2	NA		NA		NA	chromatin organization|regulation of transcription, DNA-dependent	chromatin|cytoplasm|nucleus	DNA binding|protein binding			breast(1)|lung(2)	3		all_cancers(24;1.9e-24)|Colorectal(325;3.46e-05)|all_lung(284;5.94e-05)|Lung NSC(340;7.26e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Breast(348;0.00637)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Epithelial(14;3.38e-49)|OV - Ovarian serous cystadenocarcinoma(117;5.38e-28)|Colorectal(126;1.24e-08)|COAD - Colon adenocarcinoma(152;9.31e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.000716)|BRCA - Breast invasive adenocarcinoma(304;0.000946)|STAD - Stomach adenocarcinoma(196;0.00151)|GBM - Glioblastoma multiforme(114;0.026)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.153)|LUSC - Lung squamous cell carcinoma(448;0.227)		GCAGAATTTTGTTTTACTTTT	0.313	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA			NA	NA			NA															NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000198830	HGNC:4986	NM_005517	Approved	uc001bmp.4	NA	Q0VGD5|Q6FGI5|Q96C64	ENST00000361427.5	37	CCDS283.1																																																																																			HMGN2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000009901.1	6.678849	KEEP		+	10.776641	0.195652	9	37	---	---	---	---	1	0.9986384	133	916	3	44	12	38	3	44	103	0	0	0	0	0	0	12	38	3	44	2	TP
TDRD10	126668	broad.mit.edu	37	1	154516509	154516509	+	Missense_Mutation	SNP	G	G	A	rs143192137	byFrequency	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr1:154516509G>A	ENST00000368482.4	+	9	1412	c.574G>A	c.(574-576)Gtc>Atc	p.V192I	TDRD10_ENST00000368480.3_Missense_Mutation_p.V192I|TDRD10_ENST00000479937.1_3'UTR	NM_001098475.1|NM_182499.3	NP_001091945.1|NP_872305.3	Q5VZ19	TDR10_HUMAN	tudor domain containing 10	192		NA		NA			nucleotide binding|RNA binding			breast(1)|cervix(1)|endometrium(2)|kidney(1)|large_intestine(5)|lung(14)|ovary(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	29	all_lung(78;1.72e-29)|Lung NSC(65;2.96e-27)|Hepatocellular(266;0.0877)|all_hematologic(923;0.088)		LUSC - Lung squamous cell carcinoma(543;0.185)			CATCCATAGCGTCCGTGGGGA	0.612	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	A	ILE/VAL,ILE/VAL	0,4406		0,0,2203	144	122	130		574,574	-8.7	0	1	dbSNP_134	130	4,8596	3.7+/-12.6	0,4,4296	yes	missense,missense	TDRD10	NM_001098475.1,NM_182499.3	29,29	0,4,6499	AA,AG,GG		0.0465,0.0,0.0308	benign,benign	192/367,192/352	154516509	4,13002	2203	4300	6503	SO:0001583	missense			ENSG00000163239	HGNC:25316	NM_182499	Approved	uc009wow.3	NA	A4FU09|B0QZ53|B4DXV4|Q3ZCP1|Q3ZCS7|Q5SXY7|Q6UXV2|Q8TCN3	ENST00000368482.4	37	CCDS30878.2	.	.	.	.	.	.	.	.	.	.	g	0.005	-2.214761	0.00289	0.0	4.65E-4	ENSG00000163239	ENST00000368482;ENST00000368480	T;T	0.22945	1.96;1.93	4.35	-8.69	0.00855	.	3.828960	0.01306	N	0.010464	T	0.01558	0.0050	N	0.02916	-0.46	0.09310	N	1	B;B	0.02656	0.0;0.0	B;B	0.01281	0.0;0.0	T	0.06570	-1.0819	10	0.10902	T	0.67	-0.5355	4.888	0.13713	0.2378:0.0905:0.5031:0.1686	.	192;192	Q5VZ19;Q5VZ19-2	TDR10_HUMAN;.	I	192	ENSP00000357467:V192I;ENSP00000357465:V192I	ENSP00000357465:V192I	V	+	1	0	TDRD10	152783133	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	-2.792000	0.00766	-4.537000	0.00043	-1.764000	0.00666	GTC	TDRD10-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000090703.3	128.688241	KEEP		+	133.697988	0.3125	50	110	---	---	---	---	0	0	0	1	0	248	58	136	0	248	2	1	1	475	1004	9	1316	58	136	0	248	20	TP
B3GNT2	10678	broad.mit.edu	37	2	62450208	62450208	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr2:62450208A>G	ENST00000301998.4	+	2	1105	c.853A>G	c.(853-855)Aag>Gag	p.K285E	B3GNT2_ENST00000405767.1_Missense_Mutation_p.K285E	NM_006577.5	NP_006568.2	Q9NY97	B3GN2_HUMAN	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	285		NA		NA		Golgi membrane|integral to membrane	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity			NS(1)|breast(1)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(6)|ovary(1)|pancreas(1)	18	Lung NSC(7;0.031)|all_lung(7;0.0634)		LUSC - Lung squamous cell carcinoma(7;3.55e-06)|Epithelial(17;0.0963)			TCATCGGGATAAGAAGCTGAA	0.502	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						91	91	91			NA	NA	2		NA															62450208		2203	4300	6503	SO:0001583	missense			ENSG00000170340	HGNC:15629	NM_006577	Approved	uc002sbs.3	NA	Q9NQQ9|Q9NQR0|Q9NUT9	ENST00000301998.4	37	CCDS1870.1	.	.	.	.	.	.	.	.	.	.	A	23.8	4.454048	0.84209	.	.	ENSG00000170340	ENST00000301998;ENST00000405767	T;T	0.49139	0.79;0.79	5.9	5.9	0.94986	.	0.140018	0.64402	D	0.000005	T	0.67163	0.2864	M	0.80847	2.515	0.80722	D	1	D	0.59357	0.985	P	0.61003	0.882	T	0.66496	-0.5909	10	0.30078	T	0.28	.	16.3322	0.83039	1.0:0.0:0.0:0.0	.	285	Q9NY97	B3GN2_HUMAN	E	285	ENSP00000305595:K285E;ENSP00000384692:K285E	ENSP00000305595:K285E	K	+	1	0	B3GNT2	62303712	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.339000	0.96797	2.251000	0.74343	0.528000	0.53228	AAG	B3GNT2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251606.2	171.014567	KEEP		+	177.517912	0.297753	53	125	---	---	---	---	1	0.9999743	18	26	0	219	54	135	0	219	2	1	1	98	189	1	299	54	135	0	219	6	TP
PSD4	23550	broad.mit.edu	37	2	113950118	113950118	+	Missense_Mutation	SNP	G	G	A	rs140435814	byFrequency	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr2:113950118G>A	ENST00000245796.6	+	6	1985	c.1790G>A	c.(1789-1791)cGc>cAc	p.R597H	PSD4_ENST00000441564.2_Missense_Mutation_p.R569H	NM_012455.2	NP_036587.2	Q8NDX1	PSD4_HUMAN	pleckstrin and Sec7 domain containing 4	597	SEC7.	NA		NA	regulation of ARF protein signal transduction	cytoplasm|plasma membrane	ARF guanyl-nucleotide exchange factor activity			cervix(1)|endometrium(2)|large_intestine(4)|lung(13)|ovary(4)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	29						CGCCTCTATCGCCTGGAGGGC	0.597	NA	NA					NA				NA	NA	g	2	9e-04	0.0041	NA	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	9e-04	1	EXOME	NA	NA	0.0011	SNP						NA		NA		NA		0							NA		HIS/ARG	17,4389	25.3+/-52.1	1,15,2187	97	97	97		1790	-2.9	0.8	2	dbSNP_134	97	0,8600		0,0,4300	yes	missense	PSD4	NM_012455.2	29	1,15,6487	AA,AG,GG		0.0,0.3858,0.1307	benign	597/1057	113950118	17,12989	2203	4300	6503	SO:0001583	missense			ENSG00000125637	HGNC:19096	NM_012455	Approved	uc002tjc.3	NA	A6NEG7|A8K1Y0|O95621|Q4ZG34|Q6GPH8|Q8IYP4	ENST00000245796.6	37	CCDS33276.1	2	9.157509157509158E-4	2	0.0040650406504065045	0	0.0	0	0.0	0	0.0	g	5.103	0.204558	0.09704	0.003858	0.0	ENSG00000125637	ENST00000245796;ENST00000441564	T;T	0.30981	1.51;1.51	5.55	-2.87	0.05700	SEC7-like (4);	0.685420	0.15168	N	0.276809	T	0.10380	0.0254	N	0.04387	-0.21	0.80722	D	1	B;B;B	0.02656	0.0;0.0;0.0	B;B;B	0.09377	0.004;0.001;0.001	T	0.44375	-0.9332	10	0.02654	T	1	.	11.4513	0.50154	0.5497:0.0:0.4503:0.0	.	255;569;597	Q59HG0;Q8NDX1-2;Q8NDX1	.;.;PSD4_HUMAN	H	597;569	ENSP00000245796:R597H;ENSP00000413997:R569H	ENSP00000245796:R597H	R	+	2	0	PSD4	113666589	0.030000	0.19436	0.776000	0.31678	0.911000	0.54048	0.236000	0.17967	-0.432000	0.07297	-0.482000	0.04802	CGC	PSD4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000330789.1	76.595711	KEEP		+	83.796713	0.255639	34	99	---	---	---	---	1	0.8496261	6	7	0	154	38	121	0	154	2	1	1	448	782	9	1195	38	121	0	154	18	TP
ZNF445	353274	broad.mit.edu	37	3	44488333	44488333	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr3:44488333G>C	ENST00000425708.2	-	7	3171	c.2830C>G	c.(2830-2832)Cta>Gta	p.L944V	ZNF445_ENST00000396077.2_Missense_Mutation_p.L944V			P59923	ZN445_HUMAN	zinc finger protein 445	944		NA		NA	viral reproduction	nucleus	DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding			breast(1)|endometrium(5)|kidney(3)|large_intestine(8)|lung(8)|ovary(2)|pancreas(1)|skin(3)	31				KIRC - Kidney renal clear cell carcinoma(197;0.0514)|Kidney(197;0.0646)		CTTGGTTTTAGCTTCTGTAAT	0.522	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						97	94	95			NA	NA	3		NA															44488333		2203	4300	6503	SO:0001583	missense			ENSG00000185219	HGNC:21018	NM_181489	Approved	uc003cnf.2	NA	Q3MJD1	ENST00000425708.2	37	CCDS2713.1	.	.	.	.	.	.	.	.	.	.	G	14.07	2.424372	0.43020	.	.	ENSG00000185219	ENST00000425708;ENST00000396077	T;T	0.05786	3.39;3.39	4.49	-3.27	0.05048	.	1.235570	0.06148	N	0.673609	T	0.02727	0.0082	N	0.20685	0.6	0.09310	N	1	B;P	0.39480	0.421;0.675	B;B	0.24541	0.054;0.054	T	0.37056	-0.9722	10	0.72032	D	0.01	.	1.2262	0.01934	0.3346:0.1649:0.3404:0.1601	.	932;944	B7ZKX2;P59923	.;ZN445_HUMAN	V	944	ENSP00000413073:L944V;ENSP00000379387:L944V	ENSP00000379387:L944V	L	-	1	2	ZNF445	44463337	.	.	0.000000	0.03702	0.257000	0.26127	.	.	-0.462000	0.06984	-0.440000	0.05779	CTA	ZNF445-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		145.418498	KEEP		-	154.436314	0.265193	48	133	---	---	---	---	1	0.6408726	3	5	0	255	48	140	0	255	2	1	1	358	478	4	892	48	140	0	255	13	TP
OR5K4	403278	broad.mit.edu	37	3	98072705	98072705	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr3:98072705G>T	ENST00000354924.2	+	1	8	c.8G>T	c.(7-9)aGg>aTg	p.R3M	RP11-325B23.2_ENST00000508616.1_lincRNA	NM_001005517.1	NP_001005517.1	A6NMS3	OR5K4_HUMAN	olfactory receptor, family 5, subfamily K, member 4	3		NA		NA	sensory perception of smell	integral to membrane|plasma membrane	olfactory receptor activity			breast(1)|central_nervous_system(1)|kidney(1)|large_intestine(4)|lung(13)|upper_aerodigestive_tract(1)	21						GGAATGGCTAGGGAAAATCAC	0.393	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						61	62	61			NA	NA	3		NA															98072705		2203	4300	6503	SO:0001583	missense			ENSG00000196098	HGNC:31291		Approved	uc011bgv.2	NA		ENST00000354924.2	37	CCDS33802.1	.	.	.	.	.	.	.	.	.	.	A	7.808	0.715128	0.15306	.	.	ENSG00000196098	ENST00000354924	T	0.09911	2.93	4.67	2.23	0.28157	.	0.495242	0.14861	U	0.294107	T	0.03477	0.0100	N	0.02960	-0.455	0.09310	N	1	B	0.19331	0.035	B	0.12156	0.007	T	0.39820	-0.9595	10	0.37606	T	0.19	-0.628	0.8464	0.01162	0.4963:0.1648:0.1798:0.159	.	3	A6NMS3	OR5K4_HUMAN	M	3	ENSP00000347003:R3M	ENSP00000347003:R3M	R	+	2	0	OR5K4	99555395	0.000000	0.05858	0.000000	0.03702	0.030000	0.12068	-0.793000	0.04589	0.054000	0.16065	-0.308000	0.09152	AGG	OR5K4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000359114.1	127.070251	KEEP		+	130.357881	0.338028	48	94	---	---	---	---	0	0	0	0	0	149	50	103	0	149	2	1	1	221	441	11	649	50	103	0	149	21	TP
LRRC31	79782	broad.mit.edu	37	3	169579511	169579511	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr3:169579511T>C	ENST00000316428.5	-	2	323	c.266A>G	c.(265-267)aAg>aGg	p.K89R	LRRC31_ENST00000523069.1_Missense_Mutation_p.K89R|LRRC31_ENST00000397805.2_5'UTR|LRRC31_ENST00000264676.5_Missense_Mutation_p.K89R	NM_001277127.1|NM_024727.2	NP_001264056.1|NP_079003.2	Q6UY01	LRC31_HUMAN	leucine rich repeat containing 31	89		NA		NA						cervix(3)|endometrium(3)|large_intestine(8)|lung(9)|ovary(2)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(2)	31	all_cancers(22;2.76e-22)|all_epithelial(15;4.73e-27)|all_lung(20;9.24e-17)|Lung NSC(18;3.85e-16)|Ovarian(172;0.000223)|Breast(254;0.197)		Lung(28;2.71e-13)|STAD - Stomach adenocarcinoma(35;0.00943)			ATCTAGACACTTGTTGACAGC	0.428	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						239	231	233			NA	NA	3		NA															169579511		1906	4119	6025	SO:0001583	missense			ENSG00000114248	HGNC:26261	NM_024727	Approved	uc003fgc.2	NA	B7ZL44|Q17RA3|Q8N848|Q9H5N5	ENST00000316428.5	37	CCDS43167.1	.	.	.	.	.	.	.	.	.	.	T	12.42	1.932826	0.34096	.	.	ENSG00000114248	ENST00000316428;ENST00000264676;ENST00000523069	T;T;T	0.53206	0.63;0.65;0.63	5.29	-3.99	0.04069	.	0.930944	0.09114	N	0.846699	T	0.28400	0.0702	N	0.20881	0.62	0.09310	N	1	B;B	0.11235	0.004;0.001	B;B	0.12156	0.007;0.001	T	0.31752	-0.9932	10	0.15499	T	0.54	-6.3413	10.6365	0.45569	0.0:0.0961:0.6384:0.2655	.	89;89	Q6UY01-2;Q6UY01	.;LRC31_HUMAN	R	89	ENSP00000325978:K89R;ENSP00000264676:K89R;ENSP00000429145:K89R	ENSP00000264676:K89R	K	-	2	0	LRRC31	171062205	0.002000	0.14202	0.247000	0.24249	0.072000	0.16883	-0.373000	0.07494	-0.545000	0.06224	-0.460000	0.05396	AAG	LRRC31-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000378699.1	500.079939	KEEP		-	508.3742	0.350711	148	274	---	---	---	---	0	0	0	0	0	471	158	303	0	471	2	1	1	754	1285	7	2019	158	303	0	471	15	TP
TLL1	7092	broad.mit.edu	37	4	166963247	166963247	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr4:166963247C>T	ENST00000061240.2	+	11	1977	c.1330C>T	c.(1330-1332)Cgt>Tgt	p.R444C	TLL1_ENST00000507499.1_Missense_Mutation_p.R444C	NM_012464.4	NP_036596.3	O43897	TLL1_HUMAN	tolloid-like 1	444	CUB 1.	NA		NA	cell differentiation|proteolysis|skeletal system development	extracellular region	calcium ion binding|metalloendopeptidase activity|zinc ion binding	p.R444C(1)		NS(1)|breast(1)|central_nervous_system(1)|endometrium(7)|kidney(4)|large_intestine(21)|lung(26)|ovary(2)|prostate(5)|skin(6)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	77	all_hematologic(180;0.221)	Melanoma(52;0.0315)|Prostate(90;0.0405)		GBM - Glioblastoma multiforme(119;0.103)		GATTGAGTTTCGTAGCAGCAG	0.368	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	skin(1)					NA						143	145	144			NA	NA	4		NA															166963247		2203	4300	6503	SO:0001583	missense			ENSG00000038295	HGNC:11843		Approved	uc003irh.2	NA	B2RMU2|Q96AN3|Q9NQS4	ENST00000061240.2	37	CCDS3811.1	.	.	.	.	.	.	.	.	.	.	C	33	5.235751	0.95240	.	.	ENSG00000038295	ENST00000061240;ENST00000507499	T;T	0.36340	1.26;1.26	5.67	5.67	0.87782	CUB (5);	0.000000	0.85682	U	0.000000	T	0.72606	0.3481	H	0.94808	3.585	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	0.984;1.0	T	0.79799	-0.1651	10	0.62326	D	0.03	.	19.774	0.96385	0.0:1.0:0.0:0.0	.	444;444	E9PD25;O43897	.;TLL1_HUMAN	C	444	ENSP00000061240:R444C;ENSP00000426082:R444C	ENSP00000061240:R444C	R	+	1	0	TLL1	167182697	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	5.935000	0.70145	2.679000	0.91253	0.591000	0.81541	CGT	TLL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000363821.1	216.589577	KEEP		+	220.850355	0.349057	74	138	---	---	---	---	0	0	0	0	0	222	79	149	0	222	2	1	1	320	636	5	786	79	149	0	222	14	TP
CMBL	134147	broad.mit.edu	37	5	10290849	10290849	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr5:10290849G>A	ENST00000296658.3	-	2	446	c.26C>T	c.(25-27)cCg>cTg	p.P9L	Y_RNA_ENST00000516532.1_RNA|CMBL_ENST00000510532.1_5'UTR	NM_138809.3	NP_620164.1	Q96DG6	CMBL_HUMAN	carboxymethylenebutenolidase homolog (Pseudomonas)	9		NA		NA		cytosol	hydrolase activity|protein binding			endometrium(1)|large_intestine(1)|lung(9)|skin(1)|stomach(1)	13						AATGTCACACGGACAAGGATA	0.468	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						118	112	114			NA	NA	5		NA															10290849		2203	4300	6503	SO:0001583	missense			ENSG00000164237	HGNC:25090	NM_138809	Approved	uc003jes.3	NA	D3DTC7|Q8TED6	ENST00000296658.3	37	CCDS3878.1	.	.	.	.	.	.	.	.	.	.	g	17.43	3.387446	0.61956	.	.	ENSG00000164237	ENST00000296658	T	0.41758	0.99	5.58	5.58	0.84498	.	0.000000	0.85682	D	0.000000	T	0.46386	0.1390	M	0.82323	2.585	0.80722	D	1	P	0.43938	0.822	B	0.33846	0.171	T	0.55379	-0.8150	10	0.37606	T	0.19	-18.777	18.5887	0.91200	0.0:0.0:1.0:0.0	.	9	Q96DG6	CMBL_HUMAN	L	9	ENSP00000296658:P9L	ENSP00000296658:P9L	P	-	2	0	CMBL	10343849	1.000000	0.71417	0.514000	0.27761	0.078000	0.17371	6.884000	0.75600	2.648000	0.89879	0.645000	0.84053	CCG	CMBL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253689.1	127.197938	KEEP		-	129.64849	0.349593	43	80	---	---	---	---	1	0.999907	17	14	0	199	54	102	0	199	2	1	1	317	574	3	992	54	102	0	199	14	TP
TRPC7	57113	broad.mit.edu	37	5	135692836	135692836	+	Silent	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr5:135692836G>A	ENST00000513104.1	-	2	522	c.240C>T	c.(238-240)aaC>aaT	p.N80N	TRPC7_ENST00000426057.2_Silent_p.N80N|TRPC7_ENST00000355180.3_Silent_p.N80N	NM_020389.2	NP_065122.1	Q9HCX4	TRPC7_HUMAN	transient receptor potential cation channel, subfamily C, member 7	80		NA		NA	axon guidance|platelet activation	integral to membrane|plasma membrane	calcium channel activity|protein binding			NS(1)|breast(3)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(12)|lung(18)|ovary(1)|prostate(3)	46			KIRC - Kidney renal clear cell carcinoma(527;0.0101)|Kidney(363;0.0233)			GCTGCAGAGCGTTCTGCCCCA	0.607	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						82	91	88			NA	NA	5		NA															135692836		2201	4298	6499	SO:0001819	synonymous_variant			ENSG00000069018	HGNC:20754	NM_020389	Approved	uc003lbn.2	NA	A1A4Z4	ENST00000513104.1	37	CCDS47267.2	.	.	.	.	.	.	.	.	.	.	G	6.726	0.502675	0.12822	.	.	ENSG00000069018	ENST00000352189;ENST00000378459;ENST00000502753	.	.	.	5.0	-5.05	0.02955	.	.	.	.	.	T	0.65407	0.2688	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.65928	-0.6049	4	.	.	.	-26.9211	16.4055	0.83662	0.7618:0.0:0.2382:0.0	.	.	.	.	C	80	.	.	R	-	1	0	TRPC7	135720735	0.219000	0.23619	0.488000	0.27440	0.967000	0.64934	-0.323000	0.07997	-1.144000	0.02862	-1.036000	0.02392	CGC	TRPC7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000366975.1	112.040151	KEEP		-	117.514999	0.294521	43	103	---	---	---	---	0	0	0	0	0	191	47	111	0	191	2	1	1	483	829	20	1405	47	111	0	191	30	TP
RNF44	22838	broad.mit.edu	37	5	175956271	175956271	+	Intron	SNP	A	A	C	rs890835	by1000genomes	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr5:175956271A>C	ENST00000274811.4	-	10	1761				RNF44_ENST00000537487.1_Intron	NM_014901.4	NP_055716.1	Q7L0R7	RNF44_HUMAN	ring finger protein 44	NA		NA		NA			zinc ion binding			endometrium(2)|lung(3)|prostate(1)|skin(1)|stomach(1)	8	all_cancers(89;0.0029)|Renal(175;0.000269)|Lung NSC(126;0.00902)|all_lung(126;0.0142)	Medulloblastoma(196;0.0208)|all_neural(177;0.0416)	Kidney(164;3.85e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)			ACCCAGGAGCAGACCTGGGCA	0.587	NA	NA					NA				NA	NA	C	1909	0.87	0.99	0.87	2184	0.77	0.9998	,	,	NA	3e-04	0.88	NA	NA	0.8737	0.9991	LOWCOV,EXOME	NA	NA	8e-04	SNP						NA		NA		NA		0							NA	C		4284,122	89.2+/-127.9	2084,116,3	49	48	48	http://www.ncbi.nlm.nih.gov/pubmed?term		-4.4	0	5	dbSNP_86	48	7614,986	211.0+/-251.7	3371,872,57	no	intron	RNF44	NM_014901.4		5455,988,60	CC,CA,AA	http://www.ncbi.nlm.nih.gov/pubmed?term	11.4651,2.769,8.5191			175956271	11898,1108	2203	4300	6503	SO:0001627	intron_variant			ENSG00000146083	HGNC:19180		Approved	uc003mek.1	NA	Q8ND05|Q9UPQ2	ENST00000274811.4	37	CCDS4404.1	1909	0.8740842490842491	487	0.9898373983739838	314	0.8674033149171271	438	0.7657342657342657	670	0.8839050131926122	C	5.281	0.237227	0.10023	0.97231	0.885349	ENSG00000146083	ENST00000506378	.	.	.	4.14	-4.41	0.03590	.	.	.	.	.	T	0.00012	0.0000	.	.	.	0.80722	P	0.0	.	.	.	.	.	.	T	0.15122	-1.0448	3	.	.	.	.	5.4137	0.16361	0.1812:0.4221:0.3167:0.08	rs890835;rs59332974;rs890835	.	.	.	G	173	.	.	C	-	1	0	RNF44	175888877	0.000000	0.05858	0.000000	0.03702	0.034000	0.12701	-5.536000	0.00115	-1.247000	0.02507	-0.232000	0.12228	TGC	RNF44-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253156.2	-1.913552	KEEP		-	7.659116	0.0625	3	45	---	---	---	---	1	0.2354309	60	0	2	68	3	47	2	68	7	0	0	0	0	0	0	3	47	2	68	2	TP
F13A1	2162	broad.mit.edu	37	6	6267040	6267040	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr6:6267040G>A	ENST00000264870.3	-	4	587	c.322C>T	c.(322-324)Cgc>Tgc	p.R108C		NM_000129.3	NP_000120.2	P00488	F13A_HUMAN	coagulation factor XIII, A1 polypeptide	108		NA		NA	peptide cross-linking|platelet activation|platelet degranulation	extracellular region|platelet alpha granule lumen	acyltransferase activity|metal ion binding|protein-glutamine gamma-glutamyltransferase activity			NS(1)|autonomic_ganglia(1)|breast(2)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(37)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	62	Ovarian(93;0.0816)	all_hematologic(90;0.152)			L-Glutamine(DB00130)	TGTGGGTAGCGACCTATGAGA	0.448	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						144	141	142			NA	NA	6		NA															6267040		2203	4300	6503	SO:0001583	missense			ENSG00000124491	HGNC:3531		Approved	uc003mwv.3	NA	Q59HA7|Q8N6X2|Q96P24|Q9BX29	ENST00000264870.3	37	CCDS4496.1	.	.	.	.	.	.	.	.	.	.	G	16.24	3.067968	0.55539	.	.	ENSG00000124491	ENST00000264870;ENST00000441301;ENST00000414279;ENST00000431222	D;D	0.86769	-2.17;-2.17	5.65	5.65	0.86999	Immunoglobulin E-set (1);Transglutaminase, N-terminal (1);Immunoglobulin-like fold (1);	0.273259	0.37530	N	0.002046	D	0.89227	0.6655	L	0.57536	1.79	0.53688	D	0.999973	D;D	0.76494	0.999;0.999	P;P	0.56474	0.799;0.596	D	0.89257	0.3595	10	0.56958	D	0.05	.	18.7279	0.91722	0.0:0.0:1.0:0.0	.	45;108	F5H080;P00488	.;F13A_HUMAN	C	108;45;108;146	ENSP00000264870:R108C;ENSP00000413334:R108C	ENSP00000264870:R108C	R	-	1	0	F13A1	6212039	1.000000	0.71417	1.000000	0.80357	0.447000	0.32167	3.933000	0.56545	2.660000	0.90430	0.655000	0.94253	CGC	F13A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000039756.3	177.304694	KEEP		-	187.265321	0.284519	68	171	---	---	---	---	1	1	141	177	0	238	75	189	0	238	2	1	1	436	969	2	1400	75	189	0	238	8	TP
SCAND3	114821	broad.mit.edu	37	6	28539828	28539828	+	Missense_Mutation	SNP	C	C	T	rs140560647		GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr6:28539828C>T	ENST00000452236.2	-	4	4455	c.3838G>A	c.(3838-3840)Gga>Aga	p.G1280R		NM_052923.1	NP_443155.1	Q6R2W3	SCND3_HUMAN	SCAN domain containing 3	1280		NA		NA	DNA integration|viral reproduction	nucleus	DNA binding|protein dimerization activity|sequence-specific DNA binding transcription factor activity			NS(3)|autonomic_ganglia(1)|breast(5)|central_nervous_system(1)|endometrium(2)|kidney(3)|large_intestine(14)|liver(1)|lung(29)|ovary(2)|prostate(1)|skin(6)|upper_aerodigestive_tract(3)	71						gtagagaatccggtctcacag	0.353	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	C	ARG/GLY	1,4405	2.1+/-5.4	0,1,2202	70	72	71		3838	1.7	0.7	6	dbSNP_134	71	0,8600		0,0,4300	no	missense	SCAND3	NM_052923.1	125	0,1,6502	TT,TC,CC		0.0,0.0227,0.0077	probably-damaging	1280/1326	28539828	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000232040	HGNC:13851	NM_052923	Approved	uc003nlo.3	NA	Q2NKL9|Q5SRJ3|Q8TCN2|Q96MV9|Q96PW3	ENST00000452236.2	37	CCDS34355.1	.	.	.	.	.	.	.	.	.	.	C	12.17	1.857339	0.32791	2.27E-4	0.0	ENSG00000232040	ENST00000452236	T	0.21361	2.01	2.63	1.7	0.24286	HAT dimerisation (1);Ribonuclease H-like (1);	0.086182	0.43579	D	0.000543	T	0.20901	0.0503	M	0.89214	3.015	0.25528	N	0.987305	D	0.57571	0.98	P	0.50231	0.635	T	0.04090	-1.0978	10	0.59425	D	0.04	.	7.1505	0.25608	0.0:0.7194:0.2806:0.0	.	1280	Q6R2W3	SCND3_HUMAN	R	1280	ENSP00000395259:G1280R	ENSP00000395259:G1280R	G	-	1	0	SCAND3	28647807	0.834000	0.29399	0.711000	0.30485	0.735000	0.41995	0.728000	0.26013	0.612000	0.30071	0.655000	0.94253	GGA	SCAND3-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000043551.3	181.55504	KEEP		-	182.396817	0.416058	57	80	---	---	---	---	0	0.5282478	0	4	0	111	59	88	0	111	2	1	1	246	497	10	711	59	88	0	111	20	TP
C6orf165	154313	broad.mit.edu	37	6	88140868	88140868	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr6:88140868C>T	ENST00000507897.1	+	10	1360	c.1277C>T	c.(1276-1278)gCa>gTa	p.A426V	C6ORF165_ENST00000369562.4_Missense_Mutation_p.A426V			Q8IYR0	CF165_HUMAN	chromosome 6 open reading frame 165	426		NA		NA						NS(1)|central_nervous_system(1)|large_intestine(5)|lung(8)|prostate(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	19		all_cancers(76;3.93e-06)|Acute lymphoblastic leukemia(125;3.55e-10)|Prostate(29;3.51e-09)|all_hematologic(105;3.29e-06)|all_epithelial(107;0.00575)		BRCA - Breast invasive adenocarcinoma(108;0.0419)		ACGTTTGCTGCAACAGATGGT	0.378	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						103	93	96			NA	NA	6		NA															88140868		2203	4300	6503	SO:0001583	missense			ENSG00000213204	HGNC:21405	NM_178823	Approved	uc003plv.3	NA	A8K969|E1P507|Q8N9U4	ENST00000507897.1	37	CCDS34498.1	.	.	.	.	.	.	.	.	.	.	C	5.692	0.312179	0.10789	.	.	ENSG00000213204	ENST00000369562	T	0.29655	1.56	5.61	1.07	0.20283	.	1.106010	0.06483	N	0.733293	T	0.03305	0.0096	N	0.03115	-0.41	0.09310	N	1	B	0.02656	0.0	B	0.08055	0.003	T	0.40683	-0.9550	10	0.13108	T	0.6	.	4.91	0.13816	0.2817:0.4915:0.0:0.2268	.	426	Q8IYR0	CF165_HUMAN	V	426	ENSP00000358575:A426V	ENSP00000358575:A426V	A	+	2	0	C6orf165	88197587	0.001000	0.12720	0.045000	0.18777	0.446000	0.32137	0.101000	0.15251	0.263000	0.21812	0.655000	0.94253	GCA	C6orf165-001	KNOWN	basic|readthrough_transcript|CCDS	nonsense_mediated_decay	NA	protein_coding	OTTHUMT00000470406.1	106.882614	KEEP		+	114.215737	0.275	44	116	---	---	---	---	0	0	0	0	0	157	46	134	0	157	2	1	1	502	741	7	1414	46	134	0	157	14	TP
USP45	85015	broad.mit.edu	37	6	99930669	99930669	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr6:99930669G>A	ENST00000327681.6	-	8	1337	c.805C>T	c.(805-807)Cca>Tca	p.P269S	USP45_ENST00000369233.2_Missense_Mutation_p.P269S|USP45_ENST00000392738.2_Intron|USP45_ENST00000500704.2_Missense_Mutation_p.P269S|USP45_ENST00000472914.2_Missense_Mutation_p.P269S|USP45_ENST00000329966.5_Missense_Mutation_p.P269S	NM_001080481.1	NP_001073950.1	Q70EL2	UBP45_HUMAN	ubiquitin specific peptidase 45	269		NA		NA	ubiquitin-dependent protein catabolic process		cysteine-type peptidase activity|ubiquitin thiolesterase activity|zinc ion binding			NS(1)|breast(2)|central_nervous_system(1)|endometrium(5)|large_intestine(6)|lung(2)|ovary(1)|skin(1)|stomach(2)|upper_aerodigestive_tract(1)	22		all_cancers(76;0.000208)|Acute lymphoblastic leukemia(125;8.41e-11)|all_hematologic(75;2.56e-07)|all_epithelial(107;0.122)|Colorectal(196;0.133)		BRCA - Breast invasive adenocarcinoma(108;0.0718)		GGAGAAAGTGGTCCTTTTTCA	0.378	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						84	88	87			NA	NA	6		NA															99930669		2203	4300	6503	SO:0001583	missense			ENSG00000123552	HGNC:20080	NM_032929	Approved	uc003ppx.2	NA	B2RXG0|Q5T062|Q86T44|Q86TC0|Q9BRU1	ENST00000327681.6	37	CCDS34501.1	.	.	.	.	.	.	.	.	.	.	G	16.01	3.001294	0.54254	.	.	ENSG00000123552	ENST00000500704;ENST00000327681;ENST00000369233;ENST00000511403;ENST00000329966;ENST00000472914	T;T;T;T;T;T	0.73897	4.19;4.19;1.63;-0.79;1.63;1.63	5.45	4.58	0.56647	Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2 (2);	0.052308	0.85682	D	0.000000	T	0.50497	0.1619	N	0.21545	0.675	0.80722	D	1	B;P	0.34892	0.158;0.474	B;B	0.36885	0.125;0.235	T	0.58405	-0.7642	10	0.46703	T	0.11	.	14.5369	0.67966	0.0708:0.0:0.9292:0.0	.	269;269	D6RBV3;Q70EL2	.;UBP45_HUMAN	S	269;269;269;25;269;269	ENSP00000424372:P269S;ENSP00000333376:P269S;ENSP00000358236:P269S;ENSP00000423374:P25S;ENSP00000330540:P269S;ENSP00000423993:P269S	ENSP00000333376:P269S	P	-	1	0	USP45	100037390	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	6.037000	0.70956	1.444000	0.47605	0.650000	0.86243	CCA	USP45-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041609.2	142.435748	KEEP		-	147.184017	0.319018	52	111	---	---	---	---	1	0.9231075	5	6	0	152	54	119	0	152	2	1	1	251	621	7	1014	54	119	0	152	13	TP
GPNMB	10457	broad.mit.edu	37	7	23286464	23286464	+	5'UTR	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr7:23286464G>A	ENST00000258733.4	+	0	283				GPNMB_ENST00000409458.3_5'UTR|GPNMB_ENST00000381990.2_5'UTR|GPNMB_ENST00000453162.2_5'UTR|GPNMB_ENST00000539136.1_5'UTR			Q14956	GPNMB_HUMAN	glycoprotein (transmembrane) nmb	NA		NA		NA	negative regulation of cell proliferation	melanosome				breast(5)|central_nervous_system(1)|endometrium(2)|kidney(2)|large_intestine(7)|liver(2)|lung(17)|ovary(3)|stomach(2)	41			GBM - Glioblastoma multiforme(13;0.154)			GCCTGCGTCCGTGAGAATTCA	0.488	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						162	166	165			NA	NA	7		NA															23286464		2203	4300	6503	SO:0001623	5_prime_UTR_variant			ENSG00000136235	HGNC:4462	NM_001005340	Approved	uc003swc.3	NA	A4D155|Q6UVX1|Q8N1A1	ENST00000258733.4	37	CCDS5380.1																																																																																			GPNMB-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000214004.2	114.742334	KEEP		+	120.614758	0.287671	42	104	---	---	---	---	1	1	3	80	0	136	46	108	0	136	2	0	0	0	0	0	0	46	108	0	136	2	TP
AVL9	23080	broad.mit.edu	37	7	32620473	32620473	+	Missense_Mutation	SNP	G	G	C	rs150772071	byFrequency	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr7:32620473G>C	ENST00000318709.4	+	15	2023	c.1802G>C	c.(1801-1803)cGg>cCg	p.R601P	AVL9_ENST00000409301.1_Missense_Mutation_p.R583P|AVL9_ENST00000404479.1_Intron	NM_015060.1	NP_055875.1	Q8NBF6	AVL9_HUMAN	AVL9 homolog (S. cerevisiase)	601		NA		NA		integral to membrane				endometrium(3)|kidney(1)|large_intestine(3)|lung(7)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	18						ACAACTAGCCGGAATGTTGTA	0.353	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						84	79	80			NA	NA	7		NA															32620473		2203	4300	6503	SO:0001583	missense			ENSG00000105778	HGNC:28994	NM_015060	Approved	uc003tcv.1	NA	Q92573	ENST00000318709.4	37	CCDS34613.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	33|33	5.226409|5.226409	0.95173|0.95173	.|.	.|.	ENSG00000105778|ENSG00000105778	ENST00000446718|ENST00000318709;ENST00000409301;ENST00000329714	T|T;T	0.46819|0.52983	0.86|0.64;0.71	5.99|5.99	5.99|5.99	0.97316|0.97316	.|.	.|0.000000	.|0.85682	.|D	.|0.000000	T|T	0.71626|0.71626	0.3362|0.3362	M|M	0.73962|0.73962	2.25|2.25	0.80722|0.80722	D|D	1|1	.|D	.|0.89917	.|1.0	.|D	.|0.85130	.|0.997	T|T	0.72421|0.72421	-0.4299|-0.4299	7|10	0.45353|0.87932	T|D	0.12|0	-17.0983|-17.0983	20.4777|20.4777	0.99188|0.99188	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	.|601	.|Q8NBF6	.|AVL9_HUMAN	R|P	475|601;583;543	ENSP00000395134:G475R|ENSP00000315568:R601P;ENSP00000387011:R583P	ENSP00000395134:G475R|ENSP00000315568:R601P	G|R	+|+	1|2	0|0	AVL9|AVL9	32586998|32586998	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.993000|0.993000	0.82548|0.82548	9.202000|9.202000	0.95026|0.95026	2.840000|2.840000	0.97914|0.97914	0.655000|0.655000	0.94253|0.94253	GGA|CGG	AVL9-003	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000328643.1	29.035927	KEEP		+	34.078355	0.206349	13	50	---	---	---	---	1	0.9974469	18	27	0	96	14	56	0	96	2	0	0	0	0	0	0	14	56	0	96	2	TP
EGFR	1956	broad.mit.edu	37	7	55210077	55210077	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr7:55210077G>A	ENST00000275493.2	+	2	364	c.187G>A	c.(187-189)Ggg>Agg	p.G63R	EGFR_ENST00000454757.2_Missense_Mutation_p.G10R|EGFR_ENST00000342916.3_Missense_Mutation_p.G63R|EGFR_ENST00000455089.1_Missense_Mutation_p.G63R|EGFR_ENST00000344576.2_Missense_Mutation_p.G63R|EGFR_ENST00000420316.2_Missense_Mutation_p.G63R|EGFR_ENST00000442591.1_Missense_Mutation_p.G63R	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	63		NA		NA	activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.G63R(1)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GGTGGTCCTTGGGAATTTGGA	0.398	NA	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	1	Substitution - Missense(1)	central_nervous_system(1)					NA						174	167	169			NA	NA	7		NA															55210077		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	G	22.7	4.325432	0.81580	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000450046;ENST00000454757	D;D;D;D;D;D;D;D	0.89939	-2.59;-2.59;-2.59;-2.59;-2.59;-2.59;-2.59;-2.59	6.05	6.05	0.98169	EGF receptor, L domain (1);	0.096922	0.64402	D	0.000001	D	0.96002	0.8698	H	0.95187	3.635	0.37218	D	0.905126	D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0	D;D;D;D;D	0.91635	0.993;0.999;0.973;0.993;0.999	D	0.97967	1.0341	10	0.87932	D	0	.	13.4187	0.60985	0.0752:0.0:0.9248:0.0	.	63;63;63;63;63	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	R	63;63;63;63;63;63;10;10	ENSP00000415559:G63R;ENSP00000342376:G63R;ENSP00000345973:G63R;ENSP00000413843:G63R;ENSP00000275493:G63R;ENSP00000410031:G63R;ENSP00000413354:G10R;ENSP00000395243:G10R	ENSP00000275493:G63R	G	+	1	0	EGFR	55177571	1.000000	0.71417	0.998000	0.56505	0.695000	0.40330	7.677000	0.84024	2.878000	0.98634	0.650000	0.86243	GGG	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	100.620337	KEEP		+	128.112206	0.174545	48	227	---	---	---	---	1	0.9433545	6	19	0	226	52	247	0	226	2	1	1	193	799	4	912	52	247	0	226	11	TP
ZNF862	643641	broad.mit.edu	37	7	149557807	149557807	+	Nonsense_Mutation	SNP	G	G	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr7:149557807G>T	ENST00000223210.4	+	7	1803	c.1558G>T	c.(1558-1560)Gaa>Taa	p.E520*		NM_001099220.1	NP_001092690.1	O60290	ZN862_HUMAN	zinc finger protein 862	520		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	metal ion binding|nucleic acid binding|protein dimerization activity			breast(3)|central_nervous_system(1)|cervix(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(10)|ovary(1)|prostate(1)|skin(1)	34						AAAATACCATGAAGTCAGCAA	0.488	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						65	69	68			NA	NA	7		NA															149557807		2015	4171	6186	SO:0001587	stop_gained			ENSG00000106479	HGNC:34519	NM_001099220	Approved	uc010lpn.3	NA	A0AUL8	ENST00000223210.4	37	CCDS47741.1	.	.	.	.	.	.	.	.	.	.	G	39	7.615958	0.98390	.	.	ENSG00000106479	ENST00000223210	.	.	.	5.19	5.19	0.71726	.	0.000000	0.52532	D	0.000062	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.39692	T	0.17	-46.7857	14.2328	0.65906	0.0:0.0:1.0:0.0	.	.	.	.	X	520	.	ENSP00000223210:E520X	E	+	1	0	ZNF862	149188740	0.954000	0.32549	0.999000	0.59377	0.999000	0.98932	3.908000	0.56355	2.431000	0.82371	0.655000	0.94253	GAA	ZNF862-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000350165.1	83.110099	KEEP		+	94.042854	0.226415	36	123	---	---	---	---	1	0.9964721	3	31	0	142	36	126	0	142	2	0	0	0	0	0	0	36	126	0	142	2	TP
AP3M2	10947	broad.mit.edu	37	8	42023136	42023136	+	3'UTR	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr8:42023136G>A	ENST00000517922.1	+	0	933				AP3M2_ENST00000174653.3_Intron|AP3M2_ENST00000396926.3_Intron|AP3M2_ENST00000520685.1_Intron|AP3M2_ENST00000518421.1_Intron			P53677	AP3M2_HUMAN	adaptor-related protein complex 3, mu 2 subunit	NA		NA		NA	intracellular protein transport|vesicle-mediated transport	clathrin adaptor complex|Golgi apparatus				endometrium(3)|kidney(1)|large_intestine(1)|lung(10)|prostate(1)|stomach(1)	17	all_cancers(6;8.14e-25)|all_epithelial(6;2.41e-27)|all_lung(13;5.09e-13)|Lung NSC(13;8.38e-12)|Ovarian(28;0.00438)|Prostate(17;0.0119)|Colorectal(14;0.0221)|Lung SC(25;0.211)	all_lung(54;0.000434)|Lung NSC(58;0.00161)|Hepatocellular(245;0.0524)|Esophageal squamous(32;0.0954)|Renal(179;0.0983)	BRCA - Breast invasive adenocarcinoma(8;5.23e-10)|Colorectal(10;0.00165)|OV - Ovarian serous cystadenocarcinoma(14;0.00346)|Lung(22;0.00467)|COAD - Colon adenocarcinoma(11;0.0171)|LUSC - Lung squamous cell carcinoma(45;0.024)			TGTGGAAACCGTATCTGtggt	0.438	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA			NA	NA			NA															NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000070718	HGNC:570		Approved	uc003xoo.3	NA	B2RCR0|D3DSY2	ENST00000517922.1	37																																																																																				AP3M2-003	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000377003.1	94.848524	KEEP		+	99.139926	0.3	36	84	---	---	---	---	1	0.9997481	6	0	1	167	38	89	1	167	3	0	0	0	0	0	0	38	89	1	167	2	TP
CYC1	1537	broad.mit.edu	37	8	145151572	145151572	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr8:145151572T>A	ENST00000318911.4	+	5	770	c.697T>A	c.(697-699)Ttc>Atc	p.F233I	SHARPIN_ENST00000533948.1_5'Flank	NM_001916.3	NP_001907.2	P08574	CY1_HUMAN	cytochrome c-1	233		NA		NA	respiratory electron transport chain|transport	cell junction|integral to membrane|mitochondrial inner membrane|respiratory chain	electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity|heme binding			endometrium(1)|kidney(1)|large_intestine(2)|lung(8)|ovary(1)|prostate(2)	15	all_cancers(97;2.87e-11)|all_epithelial(106;2.16e-09)|Lung NSC(106;5.89e-05)|all_lung(105;0.000174)|Ovarian(258;0.0173)|Acute lymphoblastic leukemia(118;0.155)		OV - Ovarian serous cystadenocarcinoma(54;3.38e-41)|Epithelial(56;8.71e-40)|all cancers(56;3e-35)|Colorectal(110;0.055)|BRCA - Breast invasive adenocarcinoma(115;0.105)			AGGTCTCTACTTCAACCCCTA	0.582	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						86	78	80			NA	NA	8		NA															145151572		2203	4300	6503	SO:0001583	missense			ENSG00000179091	HGNC:2579	NM_001916	Approved	uc003zaz.4	NA	Q5U062|Q6FHS7	ENST00000318911.4	37	CCDS6415.1	.	.	.	.	.	.	.	.	.	.	T	33	5.261852	0.95368	.	.	ENSG00000179091	ENST00000318911	T	0.50813	0.73	5.11	5.11	0.69529	Cytochrome c domain (2);	0.056558	0.64402	D	0.000001	T	0.68007	0.2954	M	0.80616	2.505	0.51482	D	0.99992	D	0.64830	0.994	D	0.67548	0.952	T	0.73241	-0.4045	10	0.87932	D	0	-21.4065	12.8595	0.57906	0.0:0.0:0.0:1.0	.	233	P08574	CY1_HUMAN	I	233	ENSP00000317159:F233I	ENSP00000317159:F233I	F	+	1	0	CYC1	145223560	1.000000	0.71417	1.000000	0.80357	0.903000	0.53119	7.477000	0.81069	1.932000	0.55993	0.459000	0.35465	TTC	CYC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000382895.1	139.970689	KEEP		+	140.657601	0.417391	48	67	---	---	---	---	1	1	211	210	0	177	57	76	0	177	2	0	0	0	0	0	0	57	76	0	177	2	TP
DENND1A	57706	broad.mit.edu	37	9	126219637	126219637	+	Silent	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr9:126219637G>A	ENST00000373624.2	-	15	1377	c.1176C>T	c.(1174-1176)ggC>ggT	p.G392G	DENND1A_ENST00000373618.1_Silent_p.G360G|DENND1A_ENST00000394219.3_Silent_p.G360G|DENND1A_ENST00000373620.3_Silent_p.G392G|DENND1A_ENST00000473039.1_Intron|DENND1A_ENST00000394215.2_Silent_p.G362G|DENND1A_ENST00000542603.1_Silent_p.G134G	NM_020946.1	NP_065997.1	Q8TEH3	DEN1A_HUMAN	DENN/MADD domain containing 1A	392		NA		NA		cell junction|clathrin coated vesicle membrane|presynaptic membrane	guanyl-nucleotide exchange factor activity			breast(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(12)|liver(2)|lung(18)|ovary(2)|prostate(1)|skin(1)|stomach(1)	43						CAGCGTACTCGCCCATGTTGA	0.438	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						145	139	141			NA	NA	9		NA															126219637		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000119522	HGNC:29324	NM_024820	Approved	uc004bnz.1	NA	A8MZA3|B1AM80|B7Z3C8|B7Z669|D3PFD3|Q05C88|Q5VWF0|Q6PJZ5|Q8IVD6|Q9H796	ENST00000373624.2	37	CCDS35133.1																																																																																			DENND1A-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000053997.1	263.902243	KEEP		-	268.539385	0.357692	93	167	---	---	---	---	0	0.999991	0	36	0	291	105	196	0	291	2	1	1	371	926	12	1404	105	196	0	291	21	TP
PTEN	5728	broad.mit.edu	37	10	89692841	89692841	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr10:89692841G>A	ENST00000371953.3	+	5	1682	c.325G>A	c.(325-327)Gac>Aac	p.D109N		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	109	Phosphatase tensin-type.	NA		NA	activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.?(5)|p.R55fs*1(5)|p.Y27fs*1(2)|p.L108_D109del(2)|p.D109fs*6(1)|p.F56fs*2(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		TGAAGATCTTGACCAATGGCT	0.383	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""	NA		Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene	NA	"""L, E, M, O"""	53	Whole gene deletion(37)|Deletion - Frameshift(8)|Unknown(5)|Deletion - In frame(2)|Insertion - Frameshift(1)	prostate(16)|central_nervous_system(12)|skin(6)|lung(5)|haematopoietic_and_lymphoid_tissue(4)|breast(3)|ovary(3)|endometrium(2)|soft_tissue(1)|urinary_tract(1)	GRCh37	CD993696	PTEN	D	NA						123	113	117			NA	NA	10		NA															89692841		2203	4297	6500	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	34	5.353585	0.95830	.	.	ENSG00000171862	ENST00000371953	D	0.98701	-5.08	5.07	5.07	0.68467	Phosphatase tensin type (1);Dual specificity phosphatase, catalytic domain (1);	0.000000	0.85682	D	0.000000	D	0.98760	0.9583	L	0.53729	1.69	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	D	0.99659	1.0993	9	.	.	.	-9.5031	18.4584	0.90729	0.0:0.0:1.0:0.0	.	109	P60484	PTEN_HUMAN	N	109	ENSP00000361021:D109N	.	D	+	1	0	PTEN	89682821	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	9.425000	0.97467	2.318000	0.78349	0.655000	0.94253	GAC	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	140.2485	KEEP		+	140.859299	0.422414	49	67	---	---	---	---	1	1	36	28	0	191	55	71	0	191	2	1	1	401	411	5	940	55	71	0	191	11	TP
CKAP5	9793	broad.mit.edu	37	11	46792527	46792527	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr11:46792527C>T	ENST00000529230.1	-	25	3043	c.2997G>A	c.(2995-2997)ctG>ctA	p.L999L	CKAP5_ENST00000354558.3_Silent_p.L999L|CKAP5_ENST00000415402.1_Silent_p.L999L|CKAP5_ENST00000312055.5_Silent_p.L999L			Q14008	CKAP5_HUMAN	cytoskeleton associated protein 5	999		NA		NA	cell division|centrosome organization|establishment or maintenance of microtubule cytoskeleton polarity|G2/M transition of mitotic cell cycle|mitotic prometaphase|RNA transport|spindle organization	centrosome|cytosol	protein binding	p.L999L(1)		breast(1)|cervix(3)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(13)|ovary(1)|prostate(1)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	43						CCAGCCAGCCCAGAAGCTGCC	0.428	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(4;85 273 2202 4844 13323)					NA		NA		NA		1	Substitution - coding silent(1)	endometrium(1)					NA						70	70	70			NA	NA	11		NA															46792527		2201	4299	6500	SO:0001819	synonymous_variant			ENSG00000175216	HGNC:28959	NM_014756	Approved	uc001ndi.2	NA	Q05D70|Q0VAX7|Q0VAX8|Q14668|Q2TA89|Q6NSH4	ENST00000529230.1	37	CCDS31477.1																																																																																			CKAP5-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000390679.1	25.816202	KEEP		-	30.10127	0.220339	13	46	---	---	---	---	1	1	41	62	0	114	36	69	0	114	2	0	0	0	0	0	0	36	69	0	114	2	TP
NOX4	50507	broad.mit.edu	37	11	89073317	89073317	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr11:89073317G>A	ENST00000535633.1	-	15	1598	c.1288C>T	c.(1288-1290)Ctt>Ttt	p.L430F	NOX4_ENST00000527956.1_Missense_Mutation_p.L430F|NOX4_ENST00000525196.1_Missense_Mutation_p.L218F|NOX4_ENST00000532825.1_Missense_Mutation_p.L390F|NOX4_ENST00000542487.1_Missense_Mutation_p.L430F|NOX4_ENST00000531342.1_Missense_Mutation_p.L107F|NOX4_ENST00000343727.5_Missense_Mutation_p.L430F|NOX4_ENST00000413594.2_Missense_Mutation_p.L475F|NOX4_ENST00000528341.1_Missense_Mutation_p.L429F|NOX4_ENST00000424319.1_Missense_Mutation_p.L430F|NOX4_ENST00000527626.1_Missense_Mutation_p.L288F|NOX4_ENST00000534731.1_Missense_Mutation_p.L414F|NOX4_ENST00000375979.3_Missense_Mutation_p.L147F|NOX4_ENST00000263317.4_Missense_Mutation_p.L454F	NM_001143836.1|NM_016931.3	NP_001137308.1|NP_058627.1	Q9NPH5	NOX4_HUMAN	NADPH oxidase 4	454	Mediates interaction with TLR4.	NA		NA	cell aging|cell morphogenesis|inflammatory response|negative regulation of cell proliferation|superoxide anion generation	endoplasmic reticulum membrane|focal adhesion|integral to membrane|nucleus	electron carrier activity|flavin adenine dinucleotide binding|heme binding|NAD(P)H oxidase activity|nucleotide binding|oxygen sensor activity			NS(2)|central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(8)|lung(20)|ovary(2)|prostate(3)|skin(2)	44		Acute lymphoblastic leukemia(157;2.26e-05)|all_hematologic(158;0.011)				AGTCTTCTAAGCTTGTATGGT	0.323	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						114	113	113			NA	NA	11		NA															89073317		2201	4298	6499	SO:0001583	missense			ENSG00000086991	HGNC:7891	NM_016931	Approved	uc001pct.3	NA	A8K715|Q5K3R4|Q5K3R5|Q5K3R6|Q5K3R8|Q7Z7G3|Q86V92	ENST00000535633.1	37	CCDS44696.1	.	.	.	.	.	.	.	.	.	.	G	18.26	3.584633	0.65992	.	.	ENSG00000086991	ENST00000424319;ENST00000535633;ENST00000343727;ENST00000534731;ENST00000525196;ENST00000263317;ENST00000532825;ENST00000527956;ENST00000542487;ENST00000527626;ENST00000528341;ENST00000413594;ENST00000531342;ENST00000375979	D;D;D;D;D;D;D;D;D;D;D;D;D;D	0.95238	-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65;-3.65	5.55	3.62	0.41486	Ferric reductase, NAD binding (1);	0.000000	0.85682	D	0.000000	D	0.96629	0.8900	M	0.84948	2.725	0.46222	D	0.99893	P;D;D;D;B;P;D;P	0.76494	0.915;0.979;0.999;0.999;0.019;0.51;0.98;0.542	P;D;D;D;B;B;P;P	0.75020	0.835;0.952;0.983;0.985;0.018;0.228;0.887;0.489	D	0.95971	0.8970	9	.	.	.	-14.0312	8.2816	0.31904	0.1416:0.0:0.733:0.1254	.	390;288;429;218;107;147;414;454	E9PMY6;E9PR43;E9PPP2;E9PI95;Q9NPH5-3;Q9NPH5-4;Q9NPH5-6;Q9NPH5	.;.;.;.;.;.;.;NOX4_HUMAN	F	430;430;430;414;218;454;390;430;430;288;429;475;107;147	ENSP00000412446:L430F;ENSP00000440172:L430F;ENSP00000344747:L430F;ENSP00000436892:L414F;ENSP00000436716:L218F;ENSP00000263317:L454F;ENSP00000434924:L390F;ENSP00000433797:L430F;ENSP00000439373:L430F;ENSP00000436093:L288F;ENSP00000436970:L429F;ENSP00000405705:L475F;ENSP00000435039:L107F;ENSP00000365146:L147F	.	L	-	1	0	NOX4	88712965	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	2.304000	0.43655	1.313000	0.45069	0.460000	0.39030	CTT	NOX4-203	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000394051.1	160.16876	KEEP		-	166.098602	0.312169	59	130	---	---	---	---	0	0.9901513	0	19	0	120	65	144	0	120	2	1	1	275	671	14	1050	65	144	0	120	22	TP
PPP2R1B	5519	broad.mit.edu	37	11	111613292	111613292	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr11:111613292T>C	ENST00000527614.1	-	13	1717	c.1652A>G	c.(1651-1653)aAt>aGt	p.N551S	PPP2R1B_ENST00000311129.5_Missense_Mutation_p.N551S|PPP2R1B_ENST00000393055.2_Missense_Mutation_p.N424S|PPP2R1B_ENST00000426998.2_Missense_Mutation_p.N487S|PPP2R1B_ENST00000341980.6_Missense_Mutation_p.N506S|PPP2R1B_ENST00000427203.2_Missense_Mutation_p.N390S	NM_001177562.1|NM_002716.4	NP_001171033.1|NP_002707.3	P30154	2AAB_HUMAN	protein phosphatase 2, regulatory subunit A, beta	551		NA		NA			protein binding			endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(2)|liver(1)|lung(10)|prostate(1)|urinary_tract(2)	22		all_cancers(61;2.34e-15)|all_epithelial(67;1.72e-09)|Melanoma(852;1.91e-06)|all_hematologic(158;0.000405)|Acute lymphoblastic leukemia(157;0.000967)|Breast(348;0.0112)|all_neural(223;0.0281)|Medulloblastoma(222;0.0425)		BRCA - Breast invasive adenocarcinoma(274;1.13e-06)|Epithelial(105;2.36e-06)|all cancers(92;3.78e-05)|OV - Ovarian serous cystadenocarcinoma(223;0.0761)		TTTGGCCACATTGAAGCGAAC	0.368	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	T	SER/ASN,SER/ASN,SER/ASN,SER/ASN,SER/ASN	2,4400	4.2+/-10.8	0,2,2199	101	93	96		1517,1271,1652,1652,1460	5.5	1	11		96	0,8594		0,0,4297	no	missense,missense,missense,missense,missense	PPP2R1B	NM_001177562.1,NM_001177563.1,NM_002716.4,NM_181699.2,NM_181700.1	46,46,46,46,46	0,2,6496	CC,CT,TT		0.0,0.0454,0.0154	probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging	506/557,424/475,551/602,551/668,487/604	111613292	2,12994	2201	4297	6498	SO:0001583	missense			ENSG00000137713	HGNC:9303	NM_002716	Approved	uc001plw.1	NA	B0YJ69|O75620|Q8NHV8	ENST00000527614.1	37	CCDS8349.1	.	.	.	.	.	.	.	.	.	.	T	19.08	3.757230	0.69648	4.54E-4	0.0	ENSG00000137713	ENST00000311129;ENST00000426998;ENST00000527614;ENST00000427203;ENST00000341980;ENST00000393055	T;T;T;T;T;T	0.16324	2.35;2.35;2.35;2.35;2.35;2.35	5.47	5.47	0.80525	Armadillo-like helical (1);Armadillo-type fold (1);	0.181905	0.64402	D	0.000020	T	0.40886	0.1135	M	0.93062	3.375	0.58432	D	0.999993	P;P;P;P;P;B	0.45957	0.624;0.824;0.869;0.735;0.491;0.374	P;P;B;B;B;B	0.49561	0.542;0.615;0.333;0.34;0.118;0.177	T	0.53486	-0.8432	10	0.72032	D	0.01	-17.2351	13.5081	0.61495	0.0:0.0:0.0:1.0	.	424;506;390;487;551;551	A8MY67;F8W8G1;B7Z1G3;B4DWW5;P30154;P30154-2	.;.;.;.;2AAB_HUMAN;.	S	551;487;551;390;506;424	ENSP00000311344:N551S;ENSP00000410671:N487S;ENSP00000437193:N551S;ENSP00000415759:N390S;ENSP00000343317:N506S;ENSP00000376775:N424S	ENSP00000311344:N551S	N	-	2	0	PPP2R1B	111118502	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.606000	0.82863	2.080000	0.62538	0.454000	0.30748	AAT	PPP2R1B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000391298.1	69.891696	KEEP		-	73.286004	0.283951	23	58	---	---	---	---	1	0.9999966	34	24	0	95	25	60	0	95	2	0	0	0	0	0	0	25	60	0	95	2	TP
CD163	9332	broad.mit.edu	37	12	7639557	7639557	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr12:7639557C>T	ENST00000359156.4	-	9	2278	c.2076G>A	c.(2074-2076)tcG>tcA	p.S692S	CD163_ENST00000539632.1_5'Flank|CD163_ENST00000432237.2_Silent_p.S692S|CD163_ENST00000396620.3_Silent_p.S725S|CD163_ENST00000541972.1_Silent_p.S680S	NM_004244.5	NP_004235.4	Q86VB7	C163A_HUMAN	CD163 molecule	692		NA		NA	acute-phase response	extracellular region|integral to plasma membrane	protein binding|scavenger receptor activity			breast(1)|cervix(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(14)|lung(33)|ovary(6)|pancreas(2)|prostate(1)|skin(5)|urinary_tract(4)	76						ATGAATTGCACGAGGACAGTG	0.438	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	C	,	1,4405	2.1+/-5.4	0,1,2202	103	91	95		2076,2076	-11.1	0	12		95	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous,coding-synonymous	CD163	NM_004244.5,NM_203416.3	,	0,2,6501	TT,TC,CC		0.0116,0.0227,0.0154	,	692/1157,692/1122	7639557	2,13004	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000177575	HGNC:1631	NM_004244, NM_203416	Approved	uc001qsz.3	NA	C9JIG2|Q07898|Q07899|Q07900|Q07901|Q2VLH7	ENST00000359156.4	37	CCDS8578.1																																																																																			CD163-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000399396.2	111.261861	KEEP		-	115.970493	0.300752	40	93	---	---	---	---	0	1	0	571	0	169	44	104	0	169	2	1	1	457	765	4	1380	44	104	0	169	10	TP
SRGAP1	57522	broad.mit.edu	37	12	64509616	64509616	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr12:64509616G>A	ENST00000355086.3	+	18	2691	c.2167G>A	c.(2167-2169)Ggt>Agt	p.G723S	SRGAP1_ENST00000543397.1_Missense_Mutation_p.G660S|RP11-196H14.4_ENST00000535806.1_RNA|SRGAP1_ENST00000357825.3_Missense_Mutation_p.G700S	NM_020762.2	NP_065813.1	Q7Z6B7	SRGP1_HUMAN	SLIT-ROBO Rho GTPase activating protein 1	723		NA		NA	axon guidance	cytosol				breast(4)|central_nervous_system(3)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(11)|lung(26)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)	65			GBM - Glioblastoma multiforme(3;0.000139)|BRCA - Breast invasive adenocarcinoma(9;0.225)	GBM - Glioblastoma multiforme(28;0.0608)		CAGTGAGCACGGTACATTGGA	0.413	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						104	87	93			NA	NA	12		NA															64509616		2203	4300	6503	SO:0001583	missense			ENSG00000196935	HGNC:17382		Approved	uc010ssp.1	NA	Q9H8A3|Q9P2P2	ENST00000355086.3	37	CCDS8967.1	.	.	.	.	.	.	.	.	.	.	G	35	5.501678	0.96371	.	.	ENSG00000196935	ENST00000355086;ENST00000357825;ENST00000543397	T;T;T	0.18338	3.26;2.81;2.22	4.93	4.93	0.64822	Src homology-3 domain (1);	0.000000	0.35739	U	0.003006	T	0.22126	0.0533	L	0.45285	1.41	0.80722	D	1	P;P	0.46220	0.667;0.874	B;P	0.45712	0.154;0.491	T	0.01053	-1.1467	9	.	.	.	.	18.537	0.91014	0.0:0.0:1.0:0.0	.	723;660	Q7Z6B7;G5EA48	SRGP1_HUMAN;.	S	723;700;660	ENSP00000347198:G723S;ENSP00000350480:G700S;ENSP00000437948:G660S	.	G	+	1	0	SRGAP1	62795883	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	9.787000	0.99055	2.464000	0.83262	0.555000	0.69702	GGT	SRGAP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400896.1	23.659078	KEEP		+	25.360945	0.264706	9	25	---	---	---	---	1	0.9803439	12	11	0	47	10	28	0	47	2	0	0	0	0	0	0	10	28	0	47	2	TP
SYT16	83851	broad.mit.edu	37	14	62550997	62550997	+	Silent	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr14:62550997G>A	ENST00000430451.2	+	5	1715	c.1518G>A	c.(1516-1518)gcG>gcA	p.A506A		NM_031914.2	NP_114120.2	Q17RD7	SYT16_HUMAN	synaptotagmin XVI	506		NA		NA				p.A486A(2)		central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(11)|lung(12)|prostate(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(2)	35				OV - Ovarian serous cystadenocarcinoma(108;0.0438)|BRCA - Breast invasive adenocarcinoma(234;0.118)		ATGGAGGGGCGCCAGAGCTGT	0.552	NA	NA					NA				NA	NA	G	1	5e-04	NA	0.0028	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	4e-04	0.95	EXOME	NA	NA	0.001	SNP						NA		NA		NA		2	Substitution - coding silent(2)	upper_aerodigestive_tract(1)|large_intestine(1)					NA	G		1,3997		0,1,1998	93	92	92		1518	1.6	1	14		92	0,8318		0,0,4159	no	coding-synonymous	SYT16	NM_031914.2		0,1,6157	AA,AG,GG		0.0,0.025,0.0081		506/646	62550997	1,12315	1999	4159	6158	SO:0001819	synonymous_variant				HGNC:23142	NM_031914	Approved	uc001xfu.1	NA	B7ZL60|C9J8I3|Q707N2|Q7Z441|Q8IUU0|Q9BQR8	ENST00000430451.2	37	CCDS45121.1																																																																																			SYT16-001	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000411700.1	118.714151	KEEP		+	122.295665	0.328467	45	92	---	---	---	---	0	0	0	0	0	147	51	101	0	147	2	1	1	425	638	9	1201	51	101	0	147	16	TP
AHNAK2	113146	broad.mit.edu	37	14	105409667	105409667	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr14:105409667C>T	ENST00000333244.5	-	7	12240	c.12121G>A	c.(12121-12123)Gtg>Atg	p.V4041M	AHNAK2_ENST00000557457.1_Intron	NM_138420.2	NP_612429.2	Q8IVF2	AHNK2_HUMAN	AHNAK nucleoprotein 2	4041		NA		NA		nucleus				cervix(4)|endometrium(4)|large_intestine(3)|lung(14)|ovary(2)|prostate(2)|skin(1)|stomach(3)	33		all_cancers(154;0.115)|Melanoma(154;0.155)|all_epithelial(191;0.183)	all cancers(16;0.000479)|OV - Ovarian serous cystadenocarcinoma(23;0.00659)|Epithelial(46;0.0151)|GBM - Glioblastoma multiforme(11;0.116)			CCCTCGGGCACGGGGCCCTCT	0.627	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						104	110	108			NA	NA	14		NA															105409667		1886	4099	5985	SO:0001583	missense			ENSG00000185567	HGNC:20125	NM_138420	Approved	uc010axc.1	NA	Q5BKX7|Q7Z343|Q7Z358|Q7Z394|Q7Z3G0|Q86WQ6|Q8IYY1|Q8N3G4|Q96EX9	ENST00000333244.5	37	CCDS45177.1	.	.	.	.	.	.	.	.	.	.	-	0.023	-1.402119	0.01165	.	.	ENSG00000185567	ENST00000333244	T	0.01347	4.99	3.3	-6.59	0.01830	.	.	.	.	.	T	0.02083	0.0065	N	0.25890	0.77	0.09310	N	1	D	0.60575	0.988	P	0.56088	0.791	T	0.57219	-0.7849	9	0.46703	T	0.11	.	8.1202	0.30967	0.0753:0.119:0.5242:0.2814	.	4041	Q8IVF2	AHNK2_HUMAN	M	4041	ENSP00000353114:V4041M	ENSP00000353114:V4041M	V	-	1	0	AHNAK2	104480712	0.000000	0.05858	0.000000	0.03702	0.000000	0.00434	-3.368000	0.00495	-6.047000	0.00007	-2.986000	0.00079	GTG	AHNAK2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000410300.1	164.609515	KEEP		-	171.707295	0.305164	65	148	---	---	---	---	0	0	0	0	0	305	68	163	0	305	2	1	1	153	303	0	486	68	163	0	305	2	TP
NECAB2	54550	broad.mit.edu	37	16	84035467	84035467	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr16:84035467G>A	ENST00000565691.1	+	10	1551	c.829G>A	c.(829-831)Gtc>Atc	p.V277I	NECAB2_ENST00000305202.4_Missense_Mutation_p.V360I			Q7Z6G3	NECA2_HUMAN	N-terminal EF-hand calcium binding protein 2	360		NA		NA	antibiotic biosynthetic process	cytoplasm	calcium ion binding|oxidoreductase activity|protein binding			endometrium(1)|large_intestine(3)|lung(9)|ovary(2)|prostate(1)|stomach(2)|urinary_tract(1)	19						GTTCCGGCACGTCAAGGTGGA	0.647	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						61	52	55			NA	NA	16		NA															84035467		2200	4300	6500	SO:0001583	missense			ENSG00000103154	HGNC:23746	NM_019065	Approved	uc002fhd.3	NA	A2RRG3|O75547|Q6ZSK0	ENST00000565691.1	37		.	.	.	.	.	.	.	.	.	.	G	12.17	1.859073	0.32884	.	.	ENSG00000103154	ENST00000305202	T	0.31247	1.5	5.09	1.73	0.24493	Dimeric alpha-beta barrel (1);	0.472701	0.21381	N	0.075472	T	0.24509	0.0594	L	0.56396	1.775	0.29737	N	0.83739	B	0.29115	0.233	B	0.20384	0.029	T	0.12941	-1.0528	10	0.30854	T	0.27	-31.1648	7.9328	0.29912	0.2859:0.0:0.7141:0.0	.	360	Q7Z6G3	NECA2_HUMAN	I	360	ENSP00000307449:V360I	ENSP00000307449:V360I	V	+	1	0	NECAB2	82592968	0.044000	0.20184	0.230000	0.23976	0.562000	0.35680	0.918000	0.28678	0.093000	0.17368	0.561000	0.74099	GTC	NECAB2-002	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000432618.1	67.116677	KEEP		+	68.181869	0.363636	24	42	---	---	---	---	1	0.56799	2	3	0	101	26	49	0	101	2	0	0	0	0	0	0	26	49	0	101	2	TP
TLDC1	57707	broad.mit.edu	37	16	84529371	84529371	+	Missense_Mutation	SNP	C	C	T	rs146039021		GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr16:84529371C>T	ENST00000343629.6	-	3	484	c.302G>A	c.(301-303)gGa>gAa	p.G101E	TLDC1_ENST00000535580.1_Missense_Mutation_p.G74E|RP11-517C16.4_ENST00000568771.1_RNA|TLDC1_ENST00000561807.1_5'UTR	NM_020947.3	NP_065998.3			TBC/LysM-associated domain containing 1	NA		NA		NA							NA						CTCGGAGTTTCCTTTCAACAG	0.542	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	C	GLU/GLY	0,4400		0,0,2200	136	117	124		302	5.3	0.1	16	dbSNP_134	124	1,8599	1.2+/-3.3	0,1,4299	no	missense	KIAA1609	NM_020947.3	98	0,1,6499	TT,TC,CC		0.0116,0.0,0.0077	probably-damaging	101/457	84529371	1,12999	2200	4300	6500	SO:0001583	missense			ENSG00000140950	HGNC:29325	NM_020947	Approved		NA		ENST00000343629.6	37	CCDS32498.1	.	.	.	.	.	.	.	.	.	.	C	18.71	3.682701	0.68157	0.0	1.16E-4	ENSG00000140950	ENST00000343629;ENST00000535580	T;T	0.18338	2.22;2.22	5.34	5.34	0.76211	.	0.000000	0.85682	D	0.000000	T	0.43100	0.1232	M	0.76328	2.33	0.54753	D	0.999986	D;D	0.76494	0.999;0.999	D;D	0.72982	0.973;0.979	T	0.37361	-0.9709	10	0.87932	D	0	-10.3822	16.2151	0.82206	0.0:1.0:0.0:0.0	.	74;101	F5GWS3;Q6P9B6	.;K1609_HUMAN	E	101;74	ENSP00000343635:G101E;ENSP00000441997:G74E	ENSP00000343635:G101E	G	-	2	0	KIAA1609	83086872	0.989000	0.36119	0.087000	0.20705	0.411000	0.31082	4.735000	0.62051	2.479000	0.83701	0.563000	0.77884	GGA	TLDC1-001	KNOWN	upstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000433421.1	103.069365	KEEP		-	109.561114	0.274648	39	103	---	---	---	---	1	0.9964983	16	10	0	184	43	111	0	184	2	1	1	505	839	15	1212	43	111	0	184	28	TP
GSG2	83903	broad.mit.edu	37	17	3628349	3628349	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr17:3628349C>T	ENST00000325418.4	+	1	1139	c.1120C>T	c.(1120-1122)Cct>Tct	p.P374S	ITGAE_ENST00000263087.4_Intron|CTD-3195I5.3_ENST00000571741.1_RNA|ITGAE_ENST00000571185.1_Intron	NM_031965.2	NP_114171.2	Q8TF76	HASP_HUMAN	germ cell associated 2 (haspin)	374		NA		NA	cell cycle|chromatin modification|intracellular protein kinase cascade	nucleus	ATP binding|protein serine/threonine kinase activity				NA						GGACCTGACTCCTTTACAGAA	0.478	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						72	72	72			NA	NA	17		NA															3628349		2203	4300	6503	SO:0001583	missense			ENSG00000177602	HGNC:19682	NM_031965	Approved	uc002fwp.3	NA	Q5U5K3|Q96MN1|Q9BXS7	ENST00000325418.4	37	CCDS11036.1	.	.	.	.	.	.	.	.	.	.	C	8.757	0.922671	0.18056	.	.	ENSG00000177602	ENST00000325418	T	0.05199	3.48	4.61	0.242	0.15498	.	3.214470	0.01088	N	0.005131	T	0.04227	0.0117	N	0.08118	0	0.09310	N	1	B	0.12013	0.005	B	0.12156	0.007	T	0.39522	-0.9610	10	0.87932	D	0	-35.3413	4.2066	0.10491	0.1631:0.5682:0.0:0.2687	.	374	Q8TF76	HASP_HUMAN	S	374	ENSP00000325290:P374S	ENSP00000325290:P374S	P	+	1	0	GSG2	3575098	0.073000	0.21202	0.038000	0.18304	0.027000	0.11550	0.338000	0.19858	0.214000	0.20742	0.561000	0.74099	CCT	GSG2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207391.1	118.232582	KEEP		+	121.944657	0.323308	43	90	---	---	---	---	1	0.5043868	3	2	0	155	44	96	0	155	2	0	0	0	0	0	0	44	96	0	155	2	TP
TP53	7157	broad.mit.edu	37	17	7579374	7579374	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr17:7579374C>G	ENST00000420246.2	-	4	445	c.313G>C	c.(313-315)Ggc>Cgc	p.G105R	TP53_ENST00000445888.2_Missense_Mutation_p.G105R|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.G105R|TP53_ENST00000359597.4_Missense_Mutation_p.G105R|TP53_ENST00000455263.2_Missense_Mutation_p.G105R|TP53_ENST00000269305.4_Missense_Mutation_p.G105R	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	105	Interaction with HIPK1 (By similarity).|Interaction with WWOX.	NA	G -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|G -> D (in sporadic cancers; somatic mutation).|G -> R (in sporadic cancers; somatic mutation).|G -> S (in a sporadic cancer; somatic mutation).|G -> V (in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.0?(8)|p.G105C(5)|p.Q100fs*37(3)|p.G59fs*23(3)|p.G105R(2)|p.G105fs*18(1)|p.V73fs*9(1)|p.G105_T125del21(1)|p.G105S(1)|p.W91fs*13(1)|p.Y103_G112>C(1)|p.P13fs*18(1)|p.S33fs*23(1)|p.Y103_L111>L(1)|p.Y103fs*15(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		CCGTAGCTGCCCTGGTAGGTT	0.627	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	31	Deletion - Frameshift(12)|Substitution - Missense(8)|Whole gene deletion(8)|Complex - deletion inframe(2)|Deletion - In frame(1)	ovary(6)|lung(5)|bone(4)|upper_aerodigestive_tract(3)|large_intestine(3)|central_nervous_system(3)|liver(2)|breast(2)|stomach(1)|haematopoietic_and_lymphoid_tissue(1)|skin(1)	GRCh37	CM043949	TP53	M	NA						55	55	55			NA	NA	17		NA															7579374		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	18.55	3.649097	0.67358	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000508793;ENST00000503591	D;D;D;D;D;D;D;D	0.99900	-7.63;-7.63;-7.63;-7.63;-7.63;-7.63;-7.63;-7.63	4.75	4.75	0.60458	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99900	0.9952	M	0.90870	3.155	0.80722	D	1	D;D;D;D;D;D;D	0.89917	1.0;0.999;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	1.0;0.993;0.995;1.0;0.999;0.997;1.0	D	0.96097	0.9066	10	0.87932	D	0	-24.4789	15.6419	0.77012	0.0:1.0:0.0:0.0	.	66;105;105;105;105;105;105	B4E095;E7EMR6;P04637-2;P04637-3;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	R	105	ENSP00000410739:G105R;ENSP00000352610:G105R;ENSP00000269305:G105R;ENSP00000398846:G105R;ENSP00000391127:G105R;ENSP00000391478:G105R;ENSP00000424104:G105R;ENSP00000426252:G105R	ENSP00000269305:G105R	G	-	1	0	TP53	7520099	1.000000	0.71417	0.206000	0.23566	0.368000	0.29767	6.208000	0.72165	2.630000	0.89119	0.655000	0.94253	GGC	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	73.61933	KEEP		-	73.725897	0.45098	23	28	---	---	---	---	1	1	155	21	0	132	23	29	0	132	2	1	1	938	949	20	2530	23	29	0	132	25	TP
ST8SIA3	51046	broad.mit.edu	37	18	55024414	55024414	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr18:55024414C>T	ENST00000324000.3	+	3	2607	c.573C>T	c.(571-573)ttC>ttT	p.F191F		NM_015879.2	NP_056963.2	O43173	SIA8C_HUMAN	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3	191		NA		NA	glycosphingolipid biosynthetic process|N-glycan processing|post-translational protein modification|protein N-linked glycosylation via asparagine	integral to Golgi membrane	alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity	p.F191F(1)		breast(2)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(8)|lung(16)|prostate(1)|skin(3)	36				READ - Rectum adenocarcinoma(59;0.19)|Colorectal(16;0.205)		GTTGCAATTTCGCCCCTACGG	0.403	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - coding silent(1)	lung(1)					NA	C		0,4406		0,0,2203	78	83	81		573	-7.1	0.8	18		81	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	ST8SIA3	NM_015879.2		0,1,6502	TT,TC,CC		0.0116,0.0,0.0077		191/381	55024414	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000177511	HGNC:14269	NM_015879	Approved	uc002lgn.3	NA	A8K0F2|Q6B085|Q9NS41	ENST00000324000.3	37	CCDS32834.1																																																																																			ST8SIA3-001	KNOWN	upstream_uORF|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000449765.1	141.638659	KEEP		+	149.129869	0.285714	52	130	---	---	---	---	0	0	0	0	0	212	60	142	0	212	2	1	1	390	825	30	1056	60	142	0	212	49	TP
CNN2	1265	broad.mit.edu	37	19	1032680	1032680	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr19:1032680C>T	ENST00000263097.4	+	4	738	c.375C>T	c.(373-375)ctC>ctT	p.L125L	CNN2_ENST00000606983.1_3'UTR|CNN2_ENST00000565096.2_Intron|CNN2_ENST00000562958.2_Silent_p.L125L|CNN2_ENST00000348419.3_Silent_p.L125L	NM_004368.2	NP_004359.1	Q99439	CNN2_HUMAN	calponin 2	125	CH.	NA		NA	actomyosin structure organization|cellular response to mechanical stimulus|regulation of actin filament-based process	cell-cell junction|stress fiber	actin binding|calmodulin binding			endometrium(1)|large_intestine(2)|lung(3)|prostate(1)|skin(3)	10		Acute lymphoblastic leukemia(61;2.53e-14)|all_hematologic(61;8.18e-10)|Lung NSC(49;1.04e-05)|all_lung(49;1.53e-05)|Breast(49;9.42e-05)|Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18)		tgtctcttctcgccctggcgg	0.587	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						30	26	27			NA	NA	19		NA															1032680		2202	4298	6500	SO:0001819	synonymous_variant			ENSG00000064666	HGNC:2156	NM_004368	Approved	uc002lqu.3	NA	A5D8U8|D6W5X9|Q92578	ENST00000263097.4	37	CCDS12053.1																																																																																			CNN2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000420293.3	35.461395	KEEP		+	36.818002	0.309524	13	29	---	---	---	---	1	1	85	140	0	47	15	30	0	47	2	0	0	0	0	0	0	15	30	0	47	2	TP
TLE2	7089	broad.mit.edu	37	19	3005947	3005947	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr19:3005947C>T	ENST00000262953.6	-	16	1782	c.1520G>A	c.(1519-1521)cGt>cAt	p.R507H	TLE2_ENST00000591529.1_Missense_Mutation_p.R521H|TLE2_ENST00000447365.2_Missense_Mutation_p.R174H|TLE2_ENST00000443826.3_Missense_Mutation_p.R385H|TLE2_ENST00000426948.2_Missense_Mutation_p.R521H|TLE2_ENST00000455444.2_Missense_Mutation_p.R385H|TLE2_ENST00000590536.1_Missense_Mutation_p.R508H|TLE2_ENST00000586422.1_Intron	NM_003260.4	NP_003251.2	Q04725	TLE2_HUMAN	transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)	507		NA		NA	negative regulation of canonical Wnt receptor signaling pathway|negative regulation of transcription, DNA-dependent|organ morphogenesis|transcription, DNA-dependent|Wnt receptor signaling pathway	nucleus	protein binding|transcription corepressor activity			breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(6)|prostate(1)	13				UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18)		CTTGCAGGAACGAATGTAGTT	0.632	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						33	39	37			NA	NA	19		NA															3005947		2169	4286	6455	SO:0001583	missense				HGNC:11838	NM_003260	Approved	uc002lww.3	NA	Q8WVY0|Q9Y6S0	ENST00000262953.6	37	CCDS45911.1	.	.	.	.	.	.	.	.	.	.	C	24.9	4.583699	0.86748	.	.	ENSG00000065717	ENST00000262953;ENST00000455444;ENST00000360654;ENST00000450017;ENST00000447365;ENST00000443826;ENST00000426948	T;T;T;T;T	0.11930	2.73;2.73;2.73;2.73;2.73	3.58	2.53	0.30540	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.056202	0.64402	N	0.000001	T	0.31765	0.0807	M	0.78637	2.42	0.58432	D	0.999991	B;D;D;B;B	0.76494	0.088;0.966;0.999;0.05;0.05	B;B;P;B;B	0.62885	0.009;0.303;0.908;0.009;0.009	T	0.07385	-1.0775	10	0.87932	D	0	-12.2791	9.7352	0.40384	0.0:0.8936:0.0:0.1064	.	385;174;521;385;507	E9PEV7;B4DE62;F8WCH2;B4DE03;Q04725	.;.;.;.;TLE2_HUMAN	H	507;385;56;501;174;385;521	ENSP00000262953:R507H;ENSP00000413107:R385H;ENSP00000406523:R174H;ENSP00000392427:R385H;ENSP00000392869:R521H	ENSP00000262953:R507H	R	-	2	0	TLE2	2956947	1.000000	0.71417	0.853000	0.33588	0.918000	0.54935	7.567000	0.82357	0.828000	0.34709	0.462000	0.41574	CGT	TLE2-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000452194.2	31.782169	KEEP		-	38.265532	0.197368	15	61	---	---	---	---	1	0.9863562	16	19	0	113	17	76	0	113	2	0	0	0	0	0	0	17	76	0	113	2	TP
KIRREL2	84063	broad.mit.edu	37	19	36351505	36351505	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr19:36351505C>T	ENST00000360202.5	+	7	1062	c.864C>T	c.(862-864)ccC>ccT	p.P288P	KIRREL2_ENST00000586102.2_Silent_p.P268P|KIRREL2_ENST00000262625.7_Silent_p.P288P|KIRREL2_ENST00000592409.1_Silent_p.P288P|KIRREL2_ENST00000347900.6_Silent_p.P238P|NPHS1_ENST00000591817.1_Intron	NM_032123.5|NM_199180.2	NP_115499.4|NP_954649.2	Q6UWL6	KIRR2_HUMAN	kin of IRRE like 2 (Drosophila)	288	Ig-like C2-type 3.	NA		NA	cell adhesion	integral to membrane|plasma membrane				breast(2)|central_nervous_system(1)|endometrium(6)|large_intestine(6)|liver(2)|lung(22)|ovary(2)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	48	all_lung(56;7.14e-07)|Lung NSC(56;1.12e-06)|Esophageal squamous(110;0.162)		LUSC - Lung squamous cell carcinoma(66;0.0515)			TGACTGAGCCCGTGTCCTGCG	0.662	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						64	69	67			NA	NA	19		NA															36351505		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:18816	NM_032123	Approved	uc002ocb.4	NA	C9JHF1|C9JJ76|Q6P1R1|Q7Z5P1|Q7Z5P2|Q96IQ8|Q9H0T1	ENST00000360202.5	37	CCDS12481.1																																																																																			KIRREL2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000452561.1	55.957196	KEEP		+	64.199686	0.216216	24	87	---	---	---	---	1	0.9430489	4	15	0	133	29	98	0	133	2	0	0	0	0	0	0	29	98	0	133	2	TP
ASXL1	171023	broad.mit.edu	37	20	31022345	31022345	+	Silent	SNP	C	C	T			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr20:31022345C>T	ENST00000375687.4	+	13	2254	c.1830C>T	c.(1828-1830)ggC>ggT	p.G610G	ASXL1_ENST00000306058.5_Silent_p.G605G	NM_015338.5	NP_056153.2	Q8IXJ9	ASXL1_HUMAN	additional sex combs like 1 (Drosophila)	610		NA		NA	chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	PR-DUB complex	metal ion binding|protein binding	p.Q592fs*5(1)|p.G610G(1)		NS(1)|breast(2)|central_nervous_system(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(655)|kidney(5)|large_intestine(18)|liver(1)|lung(27)|ovary(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(1)	722						GTTGGACTGGCGCCAGGACCC	0.632	NA	NA	"""F, N, Mis"""		"""MDS, CMML"""		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		20	20q11.1	171023	additional sex combs like 1	NA	L	2	Deletion - Frameshift(1)|Substitution - coding silent(1)	haematopoietic_and_lymphoid_tissue(1)|central_nervous_system(1)					NA	C		1,4405		0,1,2202	29	31	30		1830	-10.8	0.5	20		30	1,8599		0,1,4299	no	coding-synonymous	ASXL1	NM_015338.5		0,2,6501	TT,TC,CC		0.0116,0.0227,0.0154		610/1542	31022345	2,13004	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000171456	HGNC:18318	NM_015338	Approved	uc002wxs.3	NA	B2RP59|Q5JWS9|Q8IYY7|Q9H466|Q9NQF8|Q9UFJ0|Q9UFP8|Q9Y2I4	ENST00000375687.4	37	CCDS13201.1																																																																																			ASXL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078624.2	79.623863	KEEP		+	80.762392	0.368421	28	48	---	---	---	---	1	0.9990802	13	12	0	80	30	56	0	80	2	0	0	0	0	0	0	30	56	0	80	2	TP
KRTAP10-10	353333	broad.mit.edu	37	21	46057496	46057496	+	Silent	SNP	G	G	A			GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-1034-Tumor-SM-1QUVW	GBM-TCGA-14-1034-Normal-SM-1QUVD	g.chr21:46057496G>A	ENST00000380095.1	+	1	224	c.162G>A	c.(160-162)caG>caA	p.Q54Q	TSPEAR_ENST00000323084.4_Intron	NM_181688.1	NP_859016.1	P60014	KR10A_HUMAN	keratin associated protein 10-10	54	15 X 5 AA repeats of C-C-X(3).	NA		NA		keratin filament				NS(1)|endometrium(2)|kidney(1)|lung(6)|prostate(1)|skin(2)	13						CCTGCTGCCAGACGGCCTGTG	0.657	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						56	62	60			NA	NA	21		NA															46057496		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000221859	HGNC:22972	NM_181688	Approved	uc002zfq.3	NA		ENST00000380095.1	37	CCDS33585.1																																																																																			KRTAP10-10-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000128034.1	178.940862	KEEP		+	179.078587	0.54	54	46	---	---	---	---	0	0	0	0	0	137	63	51	0	137	2	1	1	181	478	3	864	63	51	0	137	8	TP
